Abstract
Thioredoxin reductase plays a critical role in the regulation of cancer cell apoptosis, making it an attractive target for the design of new anticancer drugs. Several classes of compounds have been considered as potential antitumor or chemopreventive agents; most of them apparently interact with thioredoxin reductases C-terminal redox center.
Keywords: Thioredoxin reductase, redox system, antitumour agents, TrxR substrates, alkylating agents, reversible TrxR inhibitor, motexafin gadolinium, ethaselen, Targeting Thioredoxin Reductase, Chemopreventive Compounds, redox homeostasis, 1,2-[bis(1,2-benzisoselenazolone-3, NADPH, TrxR1 mRNA, glutathione reductase, selenenyl-sulfide, FAD domain, Cys mutant enzyme, nucleophilic, platinum compounds, efficaciousness, Motexafin Gadolinium (MGd), Aurothioglucosea, Selenodiglutathione (GS-Se-SG), peroxidase-mimicking, Anticancer Alkylating Agents, aziridinyl quinone diaziquone, Ebselene, cytotoxicity, aurothioglucose, antiproliferative agent, Curcumin, α,β-unsaturated ketone structure, carcinogenesis, mercaptoimidazole moiety, methylseleninate, nasopharyngeal (KB), TrxR inhibition, GSH, ROS
Medicinal Chemistry
Title: Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds
Volume: 6 Issue: 5
Author(s): H. H. Zeng and L. H. Wang
Affiliation:
Keywords: Thioredoxin reductase, redox system, antitumour agents, TrxR substrates, alkylating agents, reversible TrxR inhibitor, motexafin gadolinium, ethaselen, Targeting Thioredoxin Reductase, Chemopreventive Compounds, redox homeostasis, 1,2-[bis(1,2-benzisoselenazolone-3, NADPH, TrxR1 mRNA, glutathione reductase, selenenyl-sulfide, FAD domain, Cys mutant enzyme, nucleophilic, platinum compounds, efficaciousness, Motexafin Gadolinium (MGd), Aurothioglucosea, Selenodiglutathione (GS-Se-SG), peroxidase-mimicking, Anticancer Alkylating Agents, aziridinyl quinone diaziquone, Ebselene, cytotoxicity, aurothioglucose, antiproliferative agent, Curcumin, α,β-unsaturated ketone structure, carcinogenesis, mercaptoimidazole moiety, methylseleninate, nasopharyngeal (KB), TrxR inhibition, GSH, ROS
Abstract: Thioredoxin reductase plays a critical role in the regulation of cancer cell apoptosis, making it an attractive target for the design of new anticancer drugs. Several classes of compounds have been considered as potential antitumor or chemopreventive agents; most of them apparently interact with thioredoxin reductases C-terminal redox center.
Export Options
About this article
Cite this article as:
H. Zeng H. and H. Wang L., Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358864
DOI https://dx.doi.org/10.2174/157340610793358864 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Patented Biotechnological Applications of Serpin: an Update
Recent Patents on DNA & Gene Sequences Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer
Current Cancer Drug Targets SAR131675 Receptor Tyrosine Kinase Inhibitor Induces Apoptosis through Bcl- 2/Bax/Cyto c Mitochondrial Pathway in Human Umbilical Vein Endothelial Cells
Anti-Cancer Agents in Medicinal Chemistry RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
Current Cancer Drug Targets Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
Current Chemical Biology Structure-Based Virtual Screening for the Identification of High Affinity Compounds as Potent VEGFR2 Inhibitors for the Treatment of Renal Cell Carcinoma
Current Topics in Medicinal Chemistry Ribozyme- and Deoxyribozyme-Strategies for Medical Applications
Current Drug Targets MicroRNAs in Glioblastoma: Role in Pathogenesis and Opportunities for Targeted Therapies
CNS & Neurological Disorders - Drug Targets Targeted Agents for the Treatment of Advanced Renal Cell Carcinoma
Current Drug Targets Cervical Cancer: Are There Potential New Targets? An Update on Preclinical and Clinical Results
Current Drug Targets Animal Mitochondria: Evolution, Function, and Disease
Current Molecular Medicine Role of CCK/Gastrin Receptors in Gastrointestinal/Metabolic Diseases and Results of Human Studies Using Gastrin/CCK Receptor Agonists/Antagonists in these Diseases
Current Topics in Medicinal Chemistry Microfluidic Control of Hypoxia Aids Investigations of Islet Pathophysiology
Micro and Nanosystems Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review
Current Genomics Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Current Drug Targets Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Current Cancer Drug Targets Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review
Mini-Reviews in Medicinal Chemistry Arylurea Derivatives: A Class of Potential Cancer Targeting Agents
Current Topics in Medicinal Chemistry Editorial Review 2015
Current Radiopharmaceuticals